Psalm Cheung

Psalm has advised clients on a broad array of public and non-public matters, including:

• Global Infrastructure Partners, a part of BlackRock, as co-lead investor with EQT on the $33.4 billion pending acquisition of The AES Corporation (NYSE:AES) by a consortium of investors.
• Waters Corporation (NYSE: WAT) on its $17.5 billion combination with the Biosciences & Diagnostic Solutions businesses of Becton, Dickinson and Company (NYSE: BDX) through a Reverse Morris Trust transaction.
• Kellanova (NYSE: K), formerly known as the Kellogg Company, on its $35.9 billion sale to Mars, Incorporated, securing unconditional clearance from the U.S. Federal Trade Commission.
• UnitedHealth Group (NYSE: UNH) on multiple matters, including its $3.3 billion acquisition of Amedisys, Inc. (Nasdaq: AMED), securing deal clearance following litigation and settlement with the U.S. Department of Justice and four state Attorneys General; and its $600 million acquisition of Crystal Run Healthcare, securing unconditional clearance from the U.S. Department of Justice following a full-phase investigation, including Second Request compliance.
• Occidental Petroleum Corporation (NYSE: OXY) on its $12 billion acquisition of CrownRock, L.P., securing unconditional clearance from the U.S. Federal Trade Commission following a full-phase investigation, including Second Request compliance.
• Southeastern Grocers Inc. on its comprehensive strategic divestiture of its businesses, including approximately 400 Winn-Dixie and Harveys Supermarkets locations sold to ALDI, 28 Fresco y Más stores sold to Fresco Retail Group, and all of its pharmacy assets sold to CVS and Walgreens.
• Celanese Corporation (NYSE: CE) on its $11 billion acquisition of DuPont’s Mobility & Materials business following a full-phase investigation, including Second Request compliance.
• Francisco Partners on various matters across its portfolio, including:
  
  • its initial acquisition of and pending sale of Kobalt to Primary Wave Music;
  • its acquisition of Elite from TPG Capital and Thomson Reuters (TSX / Nasdaq: TRI);
  • its acquisition of AdvancedMD from Global Payments (NYSE: GPN);
  • its sale of Sourcescrub to Datasite;
  • its sale of QGenda to Hearst;
  • its $1.7 billion take-private acquisition of Sumo Logic, Inc.;
  • its acquisition of Litmos from SAP;
  • its acquisition of bswift from CVS Health;
  • its sale of Trellis Rx to CPS Solutions; and
  • BARBRI Global’s acquisition of West Academic.
• Vista Equity Partners on various matters across its portfolio.
• Boston Medical Center on its acquisition in bankruptcy of two Massachusetts hospitals from Steward Health Care.
• Invitae, a provider of genetic testing services and digital health solutions, on its bankruptcy sale to Labcorp (NYSE: LH).
• LiveVox, a provider of a cloud-based contact center as a service platform, on its sale to NICE (Nasdaq: NICE).
• Secure Energy Services Inc. (TSX: SES), a Canadian oilfield services company, on its CAD$2.3-billion enterprise value merger with Tervita Corporation before the Canadian Competition Bureau, Competition Tribunal and Federal Court of Appeal of Canada.*
• Apax Partners on its acquisition of Herjavec Group, a global cybersecurity provider founded and led by Shark Tank star, Robert Herjavec.*
• LVMH Moët Hennessy Louis Vuitton S.E. on its $15.8 billion acquisition of Tiffany & Co.*
• Fitbit, Inc. on its $2.1 billion purchase by Google LLC.*
• Equinix, Inc. (Nasdaq: EQIX) on its CAD$1.04 billion acquisition of 25 data centers from Bell Canada (NYSE: BCE).*

*Prior to joining Kirkland

Associate, Competition, Antitrust & Foreign Investment Group, Blake, Cassels & Graydon LLP, Toronto, Canada